(Q35538766)

8 August 2017

1 reference

title

Non-alcoholic fatty liver: a common manifestation of a metabolic disorder (English)

1 reference

non-alcoholic fatty liver

8 August 2017

main subject

1 reference

Malnick SD

1

1 reference

8 August 2017

S. D H. Malnick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500857

12 March 2024

M. Beergabel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500857

12 March 2024

H. Knobler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14500857

12 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

published in

QJM: An International Journal of Medicine

1 reference

8 August 2017

volume

96

1 reference

8 August 2017

issue

10

1 reference

8 August 2017

page(s)

699-709

1 reference

Clinical features and natural history of nonalcoholic steatosis syndromes

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic steatohepatitis: a study of 49 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Factors determining cirrhosis in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Excess weight risk factor for alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic Steatohepatitis in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Evaluation of abnormal liver-enzyme results in asymptomatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Distension-induced myoelectrical dysrhythmia and effect of intestinal pacing in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Fatty liver--an additional and treatable feature of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Insulin resistance in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Liver pathology and the metabolic syndrome X in severe obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Mitochondria in steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Biochemical factors in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Cytokines in alcoholic and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Post-jejunoileal-bypass Hepatic Disease: Its Similarity to Alcoholic Hepatic Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Raised hepatic free fatty acids in a patient with acute fatty liver after gastric surgery for morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Nonalcoholic Steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Hepatic iron and nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Diagnosis and management of hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Imaging of hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Effect of weight reduction on hepatic abnormalities in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Persistent hyperaminotransferasemia resolving after weight reduction in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

A risk-benefit assessment of anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Metformin reverses fatty liver disease in obese, leptin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Effect of ursodeoxycholic acid on hepatic steatosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Idiopathic steatohepatitis in childhood: a multicenter retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FQJMED%2FHCG120

21 January 2018

1

55

434

Ludwig

1980

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Nonalcoholic steatohepatitis: An expanded clinical entity

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

5

1 reference

Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

8

1 reference

Italian journal of gastroenterology and hepatology

12 March 2024

11

29

351

Lonardo

1997

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Prevalence of and risk factors for hepatic steatosis in Northern Italy

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

12

1 reference

Aviation, Space, and Environmental Medicine

12 March 2024

15

53

14

Ground

1982

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Body composition and hepatic steatosis as precursors for fibrotic liver disease

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

21

1 reference

Nonalcoholic fatty liver disease

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

23

1 reference

Steatohepatitis associated with limb lipodystrophy

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

26

1 reference

Studies of hepatic function in diabetes mellitus, portal cirrhosis and other liver diseases; a correlation of clinical, biochemical and liver needle biopsy findings

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

32

1 reference

Diabetes mellitus and liver dysfunction; etiologic and therapeutic considerations

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

33

1 reference

The incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

34

1 reference

Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimens: quantitative evaluation of their relationship with diabetes and obesity

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

36

1 reference

The American Journal of Gastroenterology

12 March 2024

37

85

1349

Silverman

1990

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

44

1 reference

Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

46

1 reference

Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

47

1 reference

Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

54

1 reference

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

59

1 reference

European Journal of Clinical Investigation

12 March 2024

60

32(suppl. 3)

24

2002

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

62

1 reference

The American Journal of Gastroenterology

12 March 2024

69

87

775

Grimm

1992

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

The American Journal of Gastroenterology

12 March 2024

70

97

2065

2002

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Characteristic sonographic signs of hepatic fatty infiltration

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

78

1 reference

Is hepatic ultrasonography a valid alternative tool to liver biopsy? Report on 507 cases studied with both techniques

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

79

1 reference

CT appearance of focal fatty infiltration of the liver

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

83

1 reference

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

86

1 reference

Digestive Diseases and Sciences

12 March 2024

94

54

374

1982

1 reference

https://api.crossref.org/works/10.1093/QJMED/HCG120

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

103

1 reference

Recurrence of nonalcoholic steatohepatitis following liver transplantation

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

106

1 reference

Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation

12 March 2024

https://api.crossref.org/works/10.1093/QJMED/HCG120

108

1 reference

12 March 2024

Identifiers

DOI

10.1093/QJMED/HCG120

1 reference

8 August 2017

1 reference